Skip to main content
Erschienen in: Head & Neck Oncology 1/2012

Open Access 01.12.2012 | Research

Computed tomography and pathological findings of five nasal neurilemmomas

verfasst von: Jing Hu, Yang-Yang Bao, Ke-Jia Cheng, Shui-Hong Zhou, Ling-Xiang Ruan, Zhou-Jun Zheng

Erschienen in: Head & Neck Oncology | Ausgabe 1/2012

Abstract

Objectives

Neurilemmomas are benign tumors deriving from Schwann cells of the nerve sheath. They occur in all parts of the body. The highest incidence of neurilemmoma is in the head and neck region (38–45%), but involvement of the nose and paranasal sinus is quite rare, with only sporadic cases having been reported in the world literature. Fewer than 4% of these tumors involve the nasal cavity and paranasal sinuses. We describe the clinical, pathologic, and computed tomography (CT) features of five nasal neurilemmomas.

Methodology

CT features of five patients with nasal schwannoma proved by operation and pathology were investigated.

Results

Schwannomas tend to be solitary and are usually well-circumscribed tumors with an oval, round or fusiform shape in the unilateral nasal cavity. The lesions usually have a mottled central lucency with peripheral intensification on contrast-enhanced CT scans. The heterogeneous appearance is related to areas of increased vascularity with adjacent non-enhancing cystic or necrotic regions.

Conclusions

Schwannoma should be considered in the differential of unusual nasal masses. Certain clinical and CT patterns may be of use in the differential diagnosis.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1758-3284-4-26) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

JH designed the manuscript. Y-YB collected the materials. K-JC aided in the surgery and collected the materials. S-HZ performed the surgery and wrote the manuscript. L-XR analysed the imaging of CT. Z-JZ performed the immunohistochemical staining and analyzed the results. All authors read and approved the final manuscript.

Background

Neurilemmomas are benign tumors deriving from Schwann cells of the nerve sheath. They occur in all parts of the body. The highest incidence of neurilemmoma is in the head and neck region (38–45%) [1, 2], but involvement of the nose and paranasal sinus is quite rare, with only sporadic cases having been reported in the world literature. Fewer than 4% of these tumors involve the nasal cavity and paranasal sinuses [3].
The clinical symptomatology of nasal neurilemmomas is varied and nonspecific. The signs and symptoms usually depend upon the location or size of the tumor and subsequent involvement of surrounding structures. Preoperative diagnosis is facilitated by endoscopy, CT, and magnetic resonance imaging (MRI) [16]. CT reveals a unilateral nasal mass that may be expansile [6]. Some features of CT is helpful in differentiating neurilemmomas from malignancies. Schwannomas can cause bone remodeling by pressure and this behavior can lead to misdiagnosis as a malignant process [6]. Preoperative correct judgement can aid to perform appropriate surgical approach [1]. To our knowledge, there are few reports more than five cases of CT features of nasal schwannoma . In this study, we describe the clinical, pathologic, and CT features of five nasal neurilemmomas.

Materials and methods

From March 2001 to Deotcember 2011, five cases of nasal neurilemmomas were surgically removed and pathologically confirmed at our hospital. The study was performed with approval of the institutional review board of institution. Informed consent was not required. We retrospectively reviewed the CT, clinical manifestations and pathological findings.
The routine CT studies, with and without intravenous contrast agent injection, were performed with contiguous 3.2 mm sections from the anterior edge of frontal sinus to the posterior edge of sphenoid sinus. CT findings were analyzed by three radiologists. All histologic slides were reviewed independently by two pathologists. The clinical data were obtained from an archive. Immunohistochemistry was performed using a streptavidin-peroxidase (SP) immunohistochemical staining technique. The primary antibodies consisted of S100 protein (polyclonal, dilution 1:300; Dako, Trappes, France).
Pathologic specimens, CT findings and clinical histories were reviewed.

Results

Summary of clinical findings in five cases of nasal neurilemmomas (Table 1)

Table 1
Clinical findings in five cases of nasal neurilemmomas
Pt
Age(years)/Sex
Location
Duration of symptoms
Symptoms
Treatment
Malignant
Follow-up
Recurrence
1
59/M
NV (right)
3 years
NO
S
No
12.8years
No
2
27/F
NV(right)
2 years
NO
S
No
12.7 years
No
3
51/M
NS(left)
10 years
NO, nasal bleeding, headache, rhinorrhea anosmia
S
No
12.3years
No
4
48/F
NS(right)
6 months
NO, nasal bleeding
S + R
No
4.8 years, died of heart diseas
No
5
56/M
NS (left)
2 months
NO, little nasal bleeding
S
No
7.8 years
No
M male, F female, NC nasal cavity, NV nasal vestibule, NO nasal obstruction, S Surgery, R Radiotherapy, NS Nasal Septum.
There were two women and three men, 27 ~ 59 years old. The mean age was 48.4 years. The history of symptoms was from two months to ten years. Clinical symptoms contributing to the diagnosis were varied and nonspecific, including epistaxis (1 case), unilateral nasal obstruction (4 cases). There were no incidences of tumor recurrence during the study period. The mean follow-up was 10.1 years (range 4.8–12.8 years).

The results of rhinoscopy and nasal endoscopy ,surgery ,CT findings and pathology(Table 2, Figures 1,2,3,4,5,6)

Table 2
The results of rhinoscopy and nasal endoscopy , surgery ,CT findings and pathology
Pt
rhinoscopy and nasal endoscopy
Findings during surgery
CT findings
pathology
1
A smooth mass in right nasal vestibule and diffuse swelling of right nasal alar and also left deviation of the columella. The tumor was tough and painless.
The tumor was completely removed via a gingivobuccal incision under local anesthesia. The tumor at right nasal vestibule was firm, ovoid, smooth, encapsulated.
CT imaging revealed that a well-defined ovoid soft tissue mass without central in the right nasal vestibule. The mass of density was uneven. The mass had an attenuation number of 17Hounsfield units (Hu) to 43Hu.On contrast CT, there was mild enhancement(20Hu~50Hu) The nasal sinuses were clear (Figure 1).
Grossly, the tumor was round, smooth, encapsulated. On cut surface, the mass was grayish, spiral and some areas was cystic. Microscopically, the tumor cells were composed of spindle cells arranged in fascicles. The tumor cells had a wavy shape, poorly defined cytoplasm, and oval nuclei with tapering ends. S-100 positive (Figure 2).
2
A firm, fixed oval mass about 1.8 cm × 1.5 cm × 1.0 cm in infer-internal of left nasal vestibule, very close to the nasal valve angle and columella was deviated to right.
The tumor was completely removed via a gingivobuccal incision under local anesthesia. The mass at left nasal vestibule was firm, round, smooth, encapsulated.
CT imaging showed that a well-defined round soft tissue mass without central in the right nasal vestibule. The mass of density was uneven(20 ~ 36Hu). There was patchy enhancement on contrast CT. The nasal sinuses were clear (Figure 3).
Grossly, the tumor was round, smooth, encapsulated. On cut surface, the mass was grayish, spiral and some areas was cystic. Microscopically, the tumor cells were composed of spindle cells arranged in fascicles with some thickened hyalinized vessels. No evidence of vascular thrombosis was observed. S-100 positive.
3
The left nasal cavity was full of lobular, light yellow mass with yellowish bleeding secretion on the surface. The nasal septum was deviated to right and was adhesion to the right inferior turbinate.
A 5.0cm × 6.0cm tumor was completely removed via lateral rhinotomy. Its pedicle was attached to the nasal septum. The external lateral wall of the left nasal was partial absorbed and the left maxillary sinus was involved.
CT scan showed that a well-defined large expansile soft-tissue mass in the left nasal cavity from choana to the inferior turbinate, which extended up to the left maxillary sinus with evidence of bony dehiscence of the internal lateral wall. The nasal septum was deviated to right. There was patchy enhancement after iodinated contrast administration, which CT value was 20Hu-41.2Hu. In addition, soft tissue density was noted in the left ethmoid sinus, compatible with sinusitis due to obstruction of the sinus orifice by the mass (Figure 4).
Grossly, the tumor was irregular, soft, unencapsulated. On cut surface, the mass was composed of gray firm tissue with a large central cystic space with yellow colored inner surface. Microscopically, A spindle cell neoplasm, with hypercellular areas and edematous hypocellular areas. Palisading nuclei consistent with Verocay bodies. S-100 strong positive.
4
A smooth tumor about 3.0 cm × 2.0cm located at the posterior left surface of nasal septum. The nasal common meatus had some pink nasal discharge.
A3.0cm × 2.0cm tumor was completely removed via lateral rhinotomy. The mass was limit to the left nasal cavity and from nasal septum.
CT scanning showed a 2.0 cm in diameter soft density mass that filling the left choana and extended into the nasopharynx. The partial bone of the nasal septum was absorbed. The left maxillary had soft tissue density compatible with sinusitis due to obstruction of the sinus orifice by the mass. CT with contrast injection showed that the mass enhanceing inhomogeneously (Figure 5).
On gross examination, the mass was encapsulated. It measured 3.0cm ×  2.0cm × 2.1cm, and it had a rubbery consistency. Microscopic examination revealed spindle cells with indistinct cell outlines and a moderate amount of cytoplasm. S-100 protein immunostaining was positive.
5
A smooth, pedunculated, gray mass covering with blood crust was in the top of left surface of nasal septum.
Endoscopic sinus surgery was carried out. The mass was about 1.0cm × 1.0cm in the anterior top of the left septum. The tumor excised completely with a safemargin of surrounding normal septal mucoperiosteum.
A well-defined, inhomogeneous, 1.0 cm × 1.0cm soft mass that located at the anterior of the left nasal vestibule was observed by CT scan. The mass had an attenuation number of 17 (Hu). The bilateral frontal, sphenoid nasal sinuses were clear and the bilateral maxillary and ethmoid sinuses were lower density due to obstruction of the sinus orifice by the mass. There was homogeneous enhancement on contrast CT(50Hu) (Figure 6).
Grossly, the tumor was round, smooth, encapsulated. On cut surface, the mass was grayish, spiral and some areas was cystic. A Pathological examination shows high cellular density and palisading pattern.The tumor cells are immunoreactive for S-100 protein.

Discussion

Neurilemmomas are usually composed of Schwann cells and are consequently also called schwannomas. Neurilemmomas can basically develop anywhere in the body, arising from the myelin sheaths of peripheral motor, sensory, sympathetic, and cranial nerves. The optic and olfactory cranial nerves are not potential sites of origin because they lack sheaths that contain Schwann cells [3]. The most common neurilemmoma in the head and neck is an acoustic neuroma arising from the eighth cranial nerve [4]. Only 4% involve the nasal cavity and paranasal sinuses. Neurilemmomas are predominantly benign, and the English literature only contains isolated cases of malignant schwannomas [5, 6]. Tumor incidence in the sinonasal tract is not related to sex or age, with cases occurring in children and the elderly[4, 715].In our present study, all five cases occurred in the nasal cavity, with two in the nasal vestibule and three in the nasal septum. The female/male ratio was 2:3, with an age range from 27 to 59 years and a median age of 48 years. Localization to the nasal septum and the nasal vestibule is exceedingly rare. The occurrence in the nasal septum is rare, with only 18 reported cases in the English literature. Malignant neurilemmoma of the nasal septum is extremely rare [8].
The clinical symptomatology is varied and nonspecific. The signs and symptoms usually depend upon the location or size of the tumor and subsequent involvement of surrounding structures, often in relation to signs of chronic nasal obstruction, such as rhinorrhea, epistaxis, and anosmia, and facial swelling [10]. Exophthalmos, facial swelling, and epiphora are less frequently observed [11]. In our present cases, the main symptom was nasal obstruction; only one other compliant, nasal bleeding, was recorded. All tumors were limited to the nasal cavity. However, these masses were easily misdiagnosed as other tumors, such as an inverted papilloma.
In general, benign neurilemmomas are well differentiated by a characteristic capsule derived from perineural cells in other locations. However, some authors have reported that neurilemmomas in the nasal cavity have been described as nonencapsulated masses [4, 12, 13]. These authors have suggested that this peculiarity could be explained by the development of these tumors from sinonasal mucosa autonomic nervous system fibers, which are devoid of perineural cells, similar to the case of gastric neurilemmoma. The absence of a capsule could be responsible for the lack of a cleavage plane and thus complicates surgical resection [14]. In our cases, however, we observed encapsulated tumors in four cases; only one case had a nonencapsulated tumor. Consequently, our cases were not consistent with the authors’ speculation. From our cases, we suggest that the lack of encapsulation does not imply malignancy.
Microscopically, neurilemmomas typically exhibit a biphasic histologic pattern of Antoni A and Antoni B areas. Antoni A areas are regions of high cellularity with spindle-shaped cells; the cells are often arranged in bundles, palisades, or whirls. Groups of compact parallel nuclei are also seen and are known as “Verocay bodies.” Antoni B areas are less cellular and do not exhibit a distinctive pattern. Additionally, neurilemmomas usually show intense immunostaining for S100 (particularly Antoni A areas), which may help to distinguish peripheral nerve sheath neoplasms from other tumors [16].We noted that the five benign nasal neurilemmomas had a mixed appearance, with Antoni A and B areas intermingled. A benign neurilemmoma of the paranasal sinuses should be differentiated from a malignant peripheral nerve sheath tumor, which is rarely described in this location.
Some findings have been reported on the special CT manifestations of neurilemmomas at other sites due to the varied pathologic changes [16, 17]. In general, Antoni A and collagen have been attributed to high density areas on CT. Antoni B, obsolete bleeding, and cystic changes have been attributed to areas of low density on CT. From this set of data and an analysis of the literature, we suggest that nasal cavity neurilemmomas have the following characteristics [3, 18, 19]:
(1)
Neurilemmomas tend to be solitary and are usually well-circumscribed tumors with an oval, round, or fusiform shape in the unilateral nasal cavity because these soft-tissue masses expand along peripheral nerves.
 
(2)
The lesions usually have a mottled central lucency with peripheral intensification on contrast-enhanced CT scans. The heterogeneous appearance is related to areas of increased vascularity with adjacent non-enhancing cystic or necrotic regions [20].
 
(3)
CT clearly depicts the relationship of the lesion to the surrounding bony structures; erosion is more common with large neurilemmomas. Bone destruction can be secondary to benign pressure erosion, and therefore such a finding should not necessarily indicate malignancy [20, 21]. Because they tend to grow slowly, radiological studies typically show expansive soft-tissue masses along with the preservation of most bony margins. This finding can be helpful in differentiating neurilemmomas from malignancies, as the latter tend to be aggressive and destroy bone [3], but intracranial extension has also been reported [19, 22]. Enlargement of neurilemmomas can lead to areas of cystic degeneration as the tumors outgrow their blood supply. Other common regressive changes are necrosis, lipidization, and formation of angiomatous clusters of blood vessels with focal thrombosis. The changes justify the adjectives that are sometimes used for these tumors.
 
As documented by previous reports [14] and also by our observations, nasal neurilemmoma commonly displays a soft-tissue mass without any distinctive features; therefore, the differential diagnosis includes a broad spectrum of lesions ranging from a neurofibroma cyst or hemangioma to malignant tumors such as melanoma and olfactory neuroblastoma.
In our present series, Case 3 was misdiagnosed as a nasal inverted papilloma. Cases 1,2, 4 and 5 were diagnosed as benign nasal tumors.
Differentiating between a neurilemmoma and neurofibroma can be particularly difficult because of the presence of overlapping histological features. Basically, neurilemmomas are often solitary and tender, with degenerative changes. Neurofibromas are more frequently multiple and associated with Von Recklinghausen’s disease; they are usually non-tender and less commonly present regressive changes. Neurofibromas are not encapsulated and are formed by a combined proliferation of all the elements of a peripheral nerve: axons, Schwann cells, fibroblasts, and probably perineural cells [23]. Malignant transformation of a neurilemmoma is exceedingly rare, but the risk increases in patients with Von Recklinghausen’s disease in whom the incidence of malignant transformation is about 10–15% [24]. On CT, neurofibromas show unclear boundaries or mild infiltration.

Conclusions

Neurilemmoma should be considered in the differential of unusual nasal masses. Certain clinical and CT patterns (i.e., a mottled central lucency with peripheral intensification on contrast-enhanced CT scans) may be of use in the differential diagnosis.

Acknowledgements

The immunohistochemical analysis for this study was supported by National Natural Science Foundation of China (No.81172562) and Department of Education of Zhejiang Provincial (No. Y201121184)
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

JH designed the manuscript. Y-YB collected the materials. K-JC aided in the surgery and collected the materials. S-HZ performed the surgery and wrote the manuscript. L-XR analysed the imaging of CT. Z-JZ performed the immunohistochemical staining and analyzed the results. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Suh JD, Ramakrishnan VR, Zhang PJ, Wu AW, Wang MB, Palmer JN, Chiu AG: Diagnosis and endoscopic management of sinonasal schwannomas. ORL J Otorhinolaryngol Relat Spec. 2011, 73: 308-312. 10.1159/000331923.CrossRefPubMed Suh JD, Ramakrishnan VR, Zhang PJ, Wu AW, Wang MB, Palmer JN, Chiu AG: Diagnosis and endoscopic management of sinonasal schwannomas. ORL J Otorhinolaryngol Relat Spec. 2011, 73: 308-312. 10.1159/000331923.CrossRefPubMed
2.
Zurück zum Zitat Ebmeyer J, Reineke U, Gehl HB, Hamberger U, Mlynski R, Essing M, Sudhoff H, Upile T: Schwannoma of the larynx. Head Neck Oncol. 2009, 1: 24-10.1186/1758-3284-1-24.PubMedCentralCrossRefPubMed Ebmeyer J, Reineke U, Gehl HB, Hamberger U, Mlynski R, Essing M, Sudhoff H, Upile T: Schwannoma of the larynx. Head Neck Oncol. 2009, 1: 24-10.1186/1758-3284-1-24.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Cakmak O, Yavuz H, Yucel T: Nasal and paranasal sinus schwannomas. Eur Arch Otorhinolaryngol. 2003, 260: 195-197.PubMed Cakmak O, Yavuz H, Yucel T: Nasal and paranasal sinus schwannomas. Eur Arch Otorhinolaryngol. 2003, 260: 195-197.PubMed
4.
Zurück zum Zitat Buob D, Wacrenier A, Chevalier D, Aubert S, Quinchon JF, Gosselin B, Leroy X: Schwannoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of 5 cases. Arch Pathol Lab Med. 2003, 127: 1196-1199.PubMed Buob D, Wacrenier A, Chevalier D, Aubert S, Quinchon JF, Gosselin B, Leroy X: Schwannoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of 5 cases. Arch Pathol Lab Med. 2003, 127: 1196-1199.PubMed
5.
Zurück zum Zitat Ogunleye AO, Ijaduola GT, Malomo AO, Oluwatosin OM, Shokunbi WA, Akinyemi OA, Oluwasola AO, Akang EE: Malignant schwannoma of the nasal cavity and paranasal sinuses in a Nigerian. Afr J Med Med Sci. 2006, 35: 489-493.PubMed Ogunleye AO, Ijaduola GT, Malomo AO, Oluwatosin OM, Shokunbi WA, Akinyemi OA, Oluwasola AO, Akang EE: Malignant schwannoma of the nasal cavity and paranasal sinuses in a Nigerian. Afr J Med Med Sci. 2006, 35: 489-493.PubMed
6.
Zurück zum Zitat Mannan AA, Singh MK, Bahadur S, Hatimota P, Sharma MC: Solitary malignant schwannoma of the nasal cavity and paranasal sinuses: report of two rare cases. Ear Nose Throat J. 2003, 82 (634–636): 638-640. Mannan AA, Singh MK, Bahadur S, Hatimota P, Sharma MC: Solitary malignant schwannoma of the nasal cavity and paranasal sinuses: report of two rare cases. Ear Nose Throat J. 2003, 82 (634–636): 638-640.
7.
Zurück zum Zitat Ulu EM, Cakmak O, Dönmez FY, Büyüklü F, Cevik B, Akdoğan V, Coşkun M: Sinonasal schwannoma of the middle turbinate. Diagn Interv Radiol. 2010, 16: 129-131.PubMed Ulu EM, Cakmak O, Dönmez FY, Büyüklü F, Cevik B, Akdoğan V, Coşkun M: Sinonasal schwannoma of the middle turbinate. Diagn Interv Radiol. 2010, 16: 129-131.PubMed
8.
Zurück zum Zitat Rajagopal S, Kaushik V, Irion K, Herd ME, Bhatnagar RK: Schwannoma of the nasal septum. Br J Radiol. 2006, 79: 16-18.CrossRef Rajagopal S, Kaushik V, Irion K, Herd ME, Bhatnagar RK: Schwannoma of the nasal septum. Br J Radiol. 2006, 79: 16-18.CrossRef
9.
Zurück zum Zitat Alessandrini M, Nucci R, Giacomini PG, Federico F, Bruno E: A case of solitary nasal schwannoma. An Otorrinolaringol Ibero Am. 2001, 28: 201-208.PubMed Alessandrini M, Nucci R, Giacomini PG, Federico F, Bruno E: A case of solitary nasal schwannoma. An Otorrinolaringol Ibero Am. 2001, 28: 201-208.PubMed
10.
Zurück zum Zitat Donnelly MJ, Al-Sader MH, Blayney AW: Benign nasal schwannoma. J Laryngol Otol. 1992, 106: 1011-1015. 10.1017/S0022215100121644.CrossRefPubMed Donnelly MJ, Al-Sader MH, Blayney AW: Benign nasal schwannoma. J Laryngol Otol. 1992, 106: 1011-1015. 10.1017/S0022215100121644.CrossRefPubMed
11.
Zurück zum Zitat Shugar MA, Montgomery WW, Reardon EJ: Management of paranasal sinus shwannomas. Ann Otol Rhinol Laryngol. 1982, 91: 65-69.CrossRefPubMed Shugar MA, Montgomery WW, Reardon EJ: Management of paranasal sinus shwannomas. Ann Otol Rhinol Laryngol. 1982, 91: 65-69.CrossRefPubMed
12.
Zurück zum Zitat Hasegawa SL, Mentzel T, Fletcher CD: Schwannomas of the sinonasal tract and nasopharynx. Mod Pathol. 1997, 10: 777-784.PubMed Hasegawa SL, Mentzel T, Fletcher CD: Schwannomas of the sinonasal tract and nasopharynx. Mod Pathol. 1997, 10: 777-784.PubMed
13.
Zurück zum Zitat Mey KH, Buchwald C, Daugaard S, Prause JU: Sinonasal schwannoma-a clinicopathological analysis of five rare cases. Rhinology. 2006, 44: 46-52.PubMed Mey KH, Buchwald C, Daugaard S, Prause JU: Sinonasal schwannoma-a clinicopathological analysis of five rare cases. Rhinology. 2006, 44: 46-52.PubMed
14.
Zurück zum Zitat Sarlomo-Rikala M, Miettinen M: Gastric schwannoma: a clinicopathological analysis of six cases. Histopathology. 1995, 27: 355-360. 10.1111/j.1365-2559.1995.tb01526.x.CrossRefPubMed Sarlomo-Rikala M, Miettinen M: Gastric schwannoma: a clinicopathological analysis of six cases. Histopathology. 1995, 27: 355-360. 10.1111/j.1365-2559.1995.tb01526.x.CrossRefPubMed
15.
Zurück zum Zitat Skouras A, Skouras G, Diab A, Asimakopoulou FA, Dimitriadi K, Divritsioti M: Schwannoma of the nasal tip: diagnosis and treatment. Aesthetic Plast Surg. 2011, 35: 657-661. 10.1007/s00266-011-9656-5.CrossRefPubMed Skouras A, Skouras G, Diab A, Asimakopoulou FA, Dimitriadi K, Divritsioti M: Schwannoma of the nasal tip: diagnosis and treatment. Aesthetic Plast Surg. 2011, 35: 657-661. 10.1007/s00266-011-9656-5.CrossRefPubMed
16.
Zurück zum Zitat Ruan LX, Zhou SH, Wang SQ: Palatine Tonsil Schwannoma: Correlation between Clinicopathology and Computed Tomography Features. J Int Med Res. 2008, 36: 1140-1147. 10.1177/147323000803600536.CrossRefPubMed Ruan LX, Zhou SH, Wang SQ: Palatine Tonsil Schwannoma: Correlation between Clinicopathology and Computed Tomography Features. J Int Med Res. 2008, 36: 1140-1147. 10.1177/147323000803600536.CrossRefPubMed
17.
Zurück zum Zitat Cohen LM, Schwartz AM, Rockoff SD: Benign schwannomas: pathologic basis for CT in homogeneities. Am J Roentgeno. 1986, 147: 141-143. 10.2214/ajr.147.1.141.CrossRef Cohen LM, Schwartz AM, Rockoff SD: Benign schwannomas: pathologic basis for CT in homogeneities. Am J Roentgeno. 1986, 147: 141-143. 10.2214/ajr.147.1.141.CrossRef
18.
Zurück zum Zitat Enion DS, Miles JB: Intracranial extension of a naso-ethmoid Schwannoma. J Laryngol Otol. 1991, 105: 578-581. 10.1017/S0022215100116664.CrossRefPubMed Enion DS, Miles JB: Intracranial extension of a naso-ethmoid Schwannoma. J Laryngol Otol. 1991, 105: 578-581. 10.1017/S0022215100116664.CrossRefPubMed
19.
Zurück zum Zitat Fujiyoshi F, Kajiya Y, Nakajo M: CT and MR imaging of nasoethmoid Schwannoma with intracranial extension. Am J Roentgenol. 1997, 169: 1754-1755. 10.2214/ajr.169.6.9393211.CrossRef Fujiyoshi F, Kajiya Y, Nakajo M: CT and MR imaging of nasoethmoid Schwannoma with intracranial extension. Am J Roentgenol. 1997, 169: 1754-1755. 10.2214/ajr.169.6.9393211.CrossRef
20.
Zurück zum Zitat Younis RT, Gross CW, Lazar RH: Schwannomas of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 1991, 117: 677-680. 10.1001/archotol.1991.01870180113022.CrossRefPubMed Younis RT, Gross CW, Lazar RH: Schwannomas of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 1991, 117: 677-680. 10.1001/archotol.1991.01870180113022.CrossRefPubMed
21.
Zurück zum Zitat Yang TL, Hsu MC, Liu CM: Nasal schwannoma: a case report and clinicopathologic analysis. Rhinology. 2001, 39: 169-172.PubMed Yang TL, Hsu MC, Liu CM: Nasal schwannoma: a case report and clinicopathologic analysis. Rhinology. 2001, 39: 169-172.PubMed
22.
Zurück zum Zitat Zovickian J, Barba D, Alksne JF: Intranasal schwannoma with extension into the intracranial compartment: case report. Neurosurg. 1986, 19: 813-815. 10.1227/00006123-198611000-00016.CrossRef Zovickian J, Barba D, Alksne JF: Intranasal schwannoma with extension into the intracranial compartment: case report. Neurosurg. 1986, 19: 813-815. 10.1227/00006123-198611000-00016.CrossRef
23.
Zurück zum Zitat Holland K, Kaye AH: Spinal tumors in neurofibromatosis-2: management considerations - a review. J Clin Neurosci. 2009, 16: 169-177. 10.1016/j.jocn.2008.03.005.CrossRefPubMed Holland K, Kaye AH: Spinal tumors in neurofibromatosis-2: management considerations - a review. J Clin Neurosci. 2009, 16: 169-177. 10.1016/j.jocn.2008.03.005.CrossRefPubMed
24.
Zurück zum Zitat Berlucchi M, Piazza C, Blanzuoli L, Battaglia G, Nicolai P: Schwannoma of the nasal septum: a case report with review of the literature. Eur Arch Otorhinolaryngol. 2000, 257: 402-405. 10.1007/s004050000242.CrossRefPubMed Berlucchi M, Piazza C, Blanzuoli L, Battaglia G, Nicolai P: Schwannoma of the nasal septum: a case report with review of the literature. Eur Arch Otorhinolaryngol. 2000, 257: 402-405. 10.1007/s004050000242.CrossRefPubMed
Metadaten
Titel
Computed tomography and pathological findings of five nasal neurilemmomas
verfasst von
Jing Hu
Yang-Yang Bao
Ke-Jia Cheng
Shui-Hong Zhou
Ling-Xiang Ruan
Zhou-Jun Zheng
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
Head & Neck Oncology / Ausgabe 1/2012
Elektronische ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-4-26

Weitere Artikel der Ausgabe 1/2012

Head & Neck Oncology 1/2012 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.